We are live on !
Find out more
BVF Inc Portfolio holdings
AUM
$3.04B
Turnover
10.42%
1-Year Est. Return
129.63%
This Fund
S&P 500
This Quarter Est. Return
+17.45%
1 Year Est. Return
+129.63%
3 Year Est. Return
+531.24%
5 Year Est. Return
+1,335.11%
10 Year Est. Return
+16,856.28%
AUM
$587M
AUM Growth
+$91.8M
(+19%)
Cap. Flow
+$8.65M
Cap. Flow % of AUM
Cap. Flow %
1.47%
Top 10 Holdings %
Top 10 Hldgs %
69.79%
Holding
31
New
4
Increased
12
Reduced
11
Closed
1
Avg Time Held
1.3
years
Top 10 Avg Time Held
1.3
years
Top 20 Avg Time Held
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTIC
CTI BioPharma
CTIC
|
+$45.1M |
| 2 |
Blueprint Medicines
BPMC
|
+$13M |
| 3 |
Alpine Immune Sciences Inc
ALPN
|
+$10.2M |
| 4 |
FPRX
Five Prime Therapeutics
FPRX
|
+$10.1M |
| 5 |
FWP
Forward Pharma
FWP
|
+$9.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ironwood Pharmaceuticals
IRWD
|
+$22.4M |
| 2 |
LOXO
Loxo Oncology
LOXO
|
+$22M |
| 3 |
Array Biopharma
ARRY
|
+$13.7M |
| 4 |
OMED
OncoMed Pharmaceuticals
OMED
|
+$7.88M |
| 5 |
ChemoCentryx
CCXI
|
+$6.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 88.92% |
| 2 | Miscellaneous | 11.08% |
Similar funds
BVF Inc's Q4 2015 Portfolio in Review
As of Q4 2015, BVF Inc held 31 positions worth $587M, up 19% from $495M the previous quarter. Its ten largest holdings account for 70% of the portfolio.
BVF Inc's Q4 2015 filing shows 4 new, 12 increased, 11 reduced and 1 closed positions. Its largest new stake was Alpine Immune Sciences Inc: 298,753 shares worth $9.25M. The largest sale was Ironwood Pharmaceuticals, an estimated $22.4M.
By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 87% a quarter earlier, followed by Miscellaneous.
- BVF Inc's largest Q4 2015 buy was Alpine Immune Sciences Inc: 298,753 shares worth $9.25M.
- BVF Inc added most to CTI BioPharma in Q4 2015, an estimated $45.1M increase.
- BVF Inc's biggest Q4 2015 reduction was Ironwood Pharmaceuticals, cutting an estimated $22.4M.
- BVF Inc fully exited Aptose Biosciences in Q4 2015, selling an estimated $179K.
- BVF Inc's ten largest holdings make up 70% of its $587M portfolio in Q4 2015.
- BVF Inc opened 4 new positions and closed 1 in Q4 2015.
- BVF Inc's portfolio value rose 19% quarter-over-quarter to $587M.
Based on BVF Inc's 13F filing for Q4 2015, filed 16 Feb 2016.